
Matthew P. Travers
Examiner (ID: 12321, Phone: (571)272-3218 , Office: P/3726 )
| Most Active Art Unit | 3726 |
| Art Unit(s) | 3726 |
| Total Applications | 906 |
| Issued Applications | 575 |
| Pending Applications | 89 |
| Abandoned Applications | 264 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18829687
[patent_doc_number] => 20230398211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => Liposomes Containing TLR4 Agonist, Preparation and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/034242
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034242
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034242 | Liposomes Containing TLR4 Agonist, Preparation and Uses Thereof | Oct 27, 2021 | Pending |
Array
(
[id] => 17412011
[patent_doc_number] => 20220046915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => COMPOSITIONS AND MEDICAL DEVICES COMPRISING ANTI-MICROBIAL PARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/513162
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513162 | COMPOSITIONS AND MEDICAL DEVICES COMPRISING ANTI-MICROBIAL PARTICLES | Oct 27, 2021 | Abandoned |
Array
(
[id] => 18752307
[patent_doc_number] => 20230355528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => LIPID NANODISC FORMATION BY POLYSACCHARIDES MODIFIED WITH HYDROPHOBIC GROUPS
[patent_app_type] => utility
[patent_app_number] => 18/029064
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029064
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029064 | LIPID NANODISC FORMATION BY POLYSACCHARIDES MODIFIED WITH HYDROPHOBIC GROUPS | Oct 19, 2021 | Pending |
Array
(
[id] => 17398014
[patent_doc_number] => 20220040104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => NANOLIPOSOME-MICROBUBBLE CONJUGATE INCLUDING DRUG FOR HAIR LOSS TREATMENT ENCAPSULATED IN NANOLIPOSOME AND COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/506490
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506490
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506490 | Nanoliposome-microbubble conjugate including drug for hair loss treatment encapsulated in nanoliposome and composition for alleviating or treating hair loss containing same | Oct 19, 2021 | Issued |
Array
(
[id] => 17398015
[patent_doc_number] => 20220040105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => NANOLIPOSOME-MICROBUBBLE CONJUGATE INCLUDING DRUG FOR HAIR LOSS TREATMENT ENCAPSULATED IN NANOLIPOSOME AND COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/506525
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506525
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506525 | Nanoliposome-microbubble conjugate including drug for hair loss treatment encapsulated in nanoliposome and composition for alleviating or treating hair loss containing same | Oct 19, 2021 | Issued |
Array
(
[id] => 17412725
[patent_doc_number] => 20220047629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Halogenated Fullerene Functionalized as a Biocidal and Chemotactic Spermicide to Vaginally Harbor and Neutralize Spermatozoa for Use as a Safe and Effective Contraceptive
[patent_app_type] => utility
[patent_app_number] => 17/499223
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499223
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499223 | Halogenated fullerene functionalized as a biocidal and chemotactic spermicide to vaginally harbor and neutralize spermatozoa for use as a safe and effective contraceptive | Oct 11, 2021 | Issued |
Array
(
[id] => 17472361
[patent_doc_number] => 20220079865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => NON-COMEDOGENIC AND NON-ACNEGENIC HAIR AND SCALP CARE FORMULATIONS AND METHOD FOR USE
[patent_app_type] => utility
[patent_app_number] => 17/496680
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/496680 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use | Oct 6, 2021 | Issued |
Array
(
[id] => 17592582
[patent_doc_number] => 20220142155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => ANTI-MICROBIAL PARTICLES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/492784
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492784
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492784 | ANTI-MICROBIAL PARTICLES AND METHODS OF USE THEREOF | Oct 3, 2021 | Abandoned |
Array
(
[id] => 17412037
[patent_doc_number] => 20220046941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => SILICA MICROCAPSULES AND METHODS OF PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 17/490576
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17490576
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/490576 | Silica microcapsules and methods of preparing same | Sep 29, 2021 | Issued |
Array
(
[id] => 19447189
[patent_doc_number] => 20240307319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => IONIZABLE LIPID MOLECULE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF LIPID NANOPARTICLE
[patent_app_type] => utility
[patent_app_number] => 18/263955
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263955
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263955 | IONIZABLE LIPID MOLECULE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF LIPID NANOPARTICLE | Sep 21, 2021 | Pending |
Array
(
[id] => 20451852
[patent_doc_number] => 12514896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Pharmaceutical composition on the basis of
[patent_app_type] => utility
[patent_app_number] => 17/478604
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1141
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478604 | Pharmaceutical composition on the basis of | Sep 16, 2021 | Issued |
Array
(
[id] => 19150187
[patent_doc_number] => 11975077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Guanylurea functionalized peptides and proteins for therapeutics
[patent_app_type] => utility
[patent_app_number] => 17/477915
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 8094
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477915 | Guanylurea functionalized peptides and proteins for therapeutics | Sep 16, 2021 | Issued |
Array
(
[id] => 18724234
[patent_doc_number] => 20230338362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/026567
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026567
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026567 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | Sep 14, 2021 | Pending |
Array
(
[id] => 19716206
[patent_doc_number] => 12201722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Nanostructured lipid carriers and stable emulsions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/470874
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 90
[patent_figures_cnt] => 149
[patent_no_of_words] => 54582
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470874
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470874 | Nanostructured lipid carriers and stable emulsions and uses thereof | Sep 8, 2021 | Issued |
Array
(
[id] => 17640685
[patent_doc_number] => 20220168423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => NANOPARTICLES OF INDIRUBIN, DERIVATIVES THEREOF AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/470163
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470163 | NANOPARTICLES OF INDIRUBIN, DERIVATIVES THEREOF AND METHODS OF MAKING AND USING SAME | Sep 8, 2021 | Abandoned |
Array
(
[id] => 18769263
[patent_doc_number] => 20230364019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => Multi-targeting cell-derived nanoparticles as a versatile theranostic
[patent_app_type] => utility
[patent_app_number] => 18/245559
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245559
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/245559 | Multi-targeting cell-derived nanoparticles as a versatile theranostic | Sep 7, 2021 | Pending |
Array
(
[id] => 19209486
[patent_doc_number] => 11998520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Methods for decreasing injuries associated with intraoperative hypotension
[patent_app_type] => utility
[patent_app_number] => 17/466778
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12997
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466778 | Methods for decreasing injuries associated with intraoperative hypotension | Sep 2, 2021 | Issued |
Array
(
[id] => 17718917
[patent_doc_number] => 20220211636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES
[patent_app_type] => utility
[patent_app_number] => 17/408135
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/408135 | MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES | Aug 19, 2021 | Abandoned |
Array
(
[id] => 18610727
[patent_doc_number] => 20230277457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => METHODS OF PREPARING LIPID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/040745
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 120307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040745
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040745 | METHODS OF PREPARING LIPID NANOPARTICLES | Aug 5, 2021 | Pending |
Array
(
[id] => 19290463
[patent_doc_number] => 12029802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Oral care compositions for active agent delivery
[patent_app_type] => utility
[patent_app_number] => 17/391089
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 41825
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/391089 | Oral care compositions for active agent delivery | Aug 1, 2021 | Issued |